Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment

Hip Arthropathy Clinical Trial

Official title:

Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04438265
• Other study ID #: PI20-1770 A.4.2
• Status: Recruiting
• Start date: September 1, 2020
• Est. completion date: December 1, 2025

Study information

• Verified date: March 2024
• Source: Hospital Medina del Campo
• Contact: Maria Teresa T Fernandez
• Phone: 637571685
• Email: maitefm70[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective of the study is to assess whether the performance of type 2 quadratus lumborum block produces an improvement in the quality of life of the patient with osteoarthritis of the hip.

Description:

The lumbar square block is an interfascial block of the posterior wall of the abdomen, initially described for the management of postoperative pain in abdominal surgery due to its suggested effect on the T7-11 roots. The analgesic efficacy of type 1 lumbar square block (QL1) in hip surgery was subsequently published. Regarding chronic pain, QL2 has been successfully performed in posttherniorrhaphy pain or pancreatic cancer.

This quadratus lumborum type 2 is performed in the patients with hip joint based on the innervation of the hip and taking the role of thoraco-lumbar fascia in the analgesia of these patients as a reference. The good results obtained in the first 5 patients have led us to evaluate whether this blockade can indeed be an analgesic alternative in patients with coxarthrosis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 1, 2025
• Est. primary completion date: September 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Sign informed consent (Annex 2)

• Age 18-85 years

• Cartilage injury (coxarthrosis) hip

• Illness <1 year of evolution

• Patients with pain after treatment with physical therapy, exercises, NSAIDs.

• EVN> 5

Exclusion Criteria:

• Refusal of the patient

• Allergy to the drugs used

• Contraindication for performing the technique

• Intraarticular treatment in the previous 3 months

• Pregnancy

Related Conditions & MeSH terms

• Chronic Hip Pain
• Hip Arthropathy
• Joint Diseases
• Ultrasound Therapy; Complications

Intervention

Drug:
• levobupivacaine
local anesthetic

Device:
• ultrasound device
scream

Locations

Country	Name	City	State
Spain	María Teresa Fernandez	Valladolid	Castilla Y León

Sponsors (3)

Lead Sponsor	Collaborator
Hospital Medina del Campo	Hospital Rio Hortega, Hospital Universitaio Getafe

Country where clinical trial is conducted

Spain, 

References & Publications (3)

Adhikary SD, El-Boghdadly K, Nasralah Z, Sarwani N, Nixon AM, Chin KJ. A radiologic and anatomic assessment of injectate spread following transmuscular quadratus lumborum block in cadavers. Anaesthesia. 2017 Jan;72(1):73-79. doi: 10.1111/anae.13647. Epub 2016 Oct 12. — View Citation

Adhikary SD, Short AJ, El-Boghdadly K, Abdelmalak MJ, Chin KJ. Transmuscular quadratus lumborum versus lumbar plexus block for total hip arthroplasty: A retrospective propensity score matched cohort study. J Anaesthesiol Clin Pharmacol. 2018 Jul-Sep;34(3):372-378. doi: 10.4103/joacp.JOACP_335_17. — View Citation

Fernandez Martin MT, Lopez Alvarez S, Ortigosa Solorzano E. Quadratus lumborum block. New approach for a chronic hip pain. Cases report. Rev Esp Anestesiol Reanim (Engl Ed). 2020 Jan;67(1):44-48. doi: 10.1016/j.redar.2019.10.001. Epub 2019 Nov 22. English, Spanish. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	relieve chronic hip pain	The main objective of the study is to assess whether the performance of type 2 lumbar .square block produces an improvement in the quality of life of the patient with osteoarthritis of the hip. The evaluation of the patient will consist of 2 stages. The first of these will consist of the evaluation consultation; evaluation with verbal numeric scale (VNS: 0 no dolor-10 the worst pain imaginable ) if patients improve their quality of pain	2 months
Secondary	rate of adverse effects of the block	find if there is complications (hematome, kidney punction...)	2 months